Weibull accelerated life tests when there are competing causes of failure (Q3923468): Difference between revisions

From MaRDI portal
Created claim: MaRDI profile type (P1460): MaRDI publication profile (Q5976449), #quickstatements; #temporary_batch_1710401496743
ReferenceBot (talk | contribs)
Changed an Item
 
(One intermediate revision by one other user not shown)
Property / full work available at URL
 
Property / full work available at URL: https://doi.org/10.1080/03610928108828174 / rank
 
Normal rank
Property / OpenAlex ID
 
Property / OpenAlex ID: W1997401892 / rank
 
Normal rank
Property / cites work
 
Property / cites work: Q3873370 / rank
 
Normal rank
Property / cites work
 
Property / cites work: Accelerated life tests under competing weibull causes of failure / rank
 
Normal rank
Property / cites work
 
Property / cites work: Calculation of small-sample weibull tolerance bounds for accelerated testing / rank
 
Normal rank

Latest revision as of 13:53, 13 June 2024

scientific article
Language Label Description Also known as
English
Weibull accelerated life tests when there are competing causes of failure
scientific article

    Statements

    Weibull accelerated life tests when there are competing causes of failure (English)
    0 references
    0 references
    0 references
    1981
    0 references
    0 references
    safe dose levels
    0 references
    Hartley and Sielkin model
    0 references
    accelerated life testing
    0 references
    Weibull distribution
    0 references
    competing causes of failure
    0 references
    maximum likelihood estimation
    0 references
    0 references